stockportfolio.pro
Stocks / ELVN vs ESTA
ELVN vs ESTA
Enliven Therapeutics, Inc. and Establishment Labs Holdings Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Enliven Therapeutics, Inc. (ELVN) | Establishment Labs Holdings Inc. (ESTA) | |
|---|---|---|
| Market cap | $2.5B | $2.4B |
| Revenue (latest FY) | $0 | $211.08M |
| Net income (latest FY) | $-103.69M | $-51.06M |
| Revenue growth (5y CAGR) | — | 20.0% |
| Net margin | — | -24.2% |
| Return on equity | -22.6% | -216.9% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ELVN — free Open ESTA — freeFrequently asked questions
Which is bigger, ELVN or ESTA?
Enliven Therapeutics, Inc. is larger by market capitalization — $2.5B versus $2.4B.
Which grows faster, ELVN or ESTA?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.